Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi !

Detection of minimal residual disease in acute promyelocytic leukemia by polymerase chain reaction assay for PML/RARalpha (retinoic acid receptor-alpha) fusion transcript. (CROSBI ID 470852)

Prilog sa skupa u zborniku | izvorni znanstveni rad | međunarodna recenzija

Nemet, Damir ; Grahovac, Blaženka ; Labar, Boris ; Mrsić, Mirando ; Bogdanić, Vinko ; Hitrec, Vlasta ; Zaher, Dunja ; Zadro, Renata ; Boban, Dubravka Detection of minimal residual disease in acute promyelocytic leukemia by polymerase chain reaction assay for PML/RARalpha (retinoic acid receptor-alpha) fusion transcript. // Molecular Oncology Today / Osmak, Maja ; Škrk, Janez (ur.). Zagreb: Croatian Ligue Against Cancer, 1996. str. 149-153-x

Podaci o odgovornosti

Nemet, Damir ; Grahovac, Blaženka ; Labar, Boris ; Mrsić, Mirando ; Bogdanić, Vinko ; Hitrec, Vlasta ; Zaher, Dunja ; Zadro, Renata ; Boban, Dubravka

engleski

Detection of minimal residual disease in acute promyelocytic leukemia by polymerase chain reaction assay for PML/RARalpha (retinoic acid receptor-alpha) fusion transcript.

Seven patients with acute promyelocytic leukemia (APL)treated with all-trans retinoic acid (ATRA) for remission (CR) induction and with chemotherapy (CT) for consolidation of CR underwent residual disease monitoring through reverse transcription polymerase chain reaction (PCR) for PML/retinoic acid receptor alpha (PML/RAR alpha) fusion transcript. In six patients PCR was positive immediately after ATRA induced CR and/or after the first CT course.Two patients became PCR negative following repeated courses of CT and they are in remission 7 and 14 months, respectively. Four other patients relapsed. This pilot study indicates that PCR for PML/RAR alpha is very sensitive assay for detection of residual disease in APL.

acute promyelocytic leukemia; PML/RAR alpha; PCR assay; all-trans retinoic acid

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o prilogu

149-153-x.

1996.

nije evidentirano

objavljeno

Podaci o matičnoj publikaciji

Molecular Oncology Today

Osmak, Maja ; Škrk, Janez

Zagreb: Croatian Ligue Against Cancer

Podaci o skupu

Nepoznat skup

pozvano predavanje

29.02.1904-29.02.2096

Povezanost rada

Kliničke medicinske znanosti